ArticleExperimental and therapeutic medicine2026
Hematopoietic cell-specific knockout Hspa9 impairs natural killer cell function and alters the Akt/mTOR axis in mice.
Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural killer (NK) cells are crucial components of the innate immune system, serving vital roles in tumor killing and antiviral immunity. Heat shock protein family A (Hsp70) member 9 (Hspa9), a molecular chaperone localized to the mitochondrial matrix and inner membrane, is essential for maintaining mitochondrial homeostasis. However, its role in regulating NK cells remains unclear. The present study aimed to investigate the impact of the Hspa9 on NK cell regulation and its underlying molecular mechanism. By knocking out Hspa9 at the hematopoietic cell stage, NK cell numbers were found to be markedly reduced in the spleen, bone marrow and liver of mice. Hspa9-deficient NK cells exhibited significantly reduced IFN-γ secretion and CD107a expression. Mechanistically, Hspa9 deficiency led to perturbed expression of surface receptors CD117, CD127 and killer cell lectin-like receptor subfamily A, member 9, which may underlie the observed alteration in maturation status. Furthermore, the impaired NK cell function may be associated with suppressed activation of the Akt/mTOR signaling pathway. In summary, the present study reveals a novel role for Hspa9 in regulating NK cell function, proposes a potential regulatory mechanism and identifies Hspa9 as a promising molecular target for modulating NK cell biology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.